This breakthrough In Vitro alternative to animal testing predicts the allergenicity of new substances.
Biovator was created to meet the growing international demand for animal-free testing of allergenicity. Strong mandates from legislators, consumers and industry are driving this significant market opportunity with an estimated worth of 190 MUSD.
Biovator’s ambition is to launch a practical platform for in vitro allergenicity testing of substances in new products. Biovator services will make animal-free testing a reality for manufacturers of food, pharmaceuticals and cosmetics as well as the many Contract Research Organizations (CROs) that are working to move new compounds into the marketplace.
Biovator’s technology platform offers distinct advantages over animal testing:
- Ethical – Meets EU directives
- Based on human cell lines (human-specific)
- Time and cost efficiency
- In vitro convenience
Read about testing and legislation, click here.
